A growing cadre of startups is pursuing iterative cycles of machine learning, wet-lab experimentation and human feedback to accelerate target drug discovery.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Structural insights into inhibition of PRRSV Nsp4 revealed by structure-based virtual screening, molecular dynamics, and MM-PBSA studies
Journal of Biological Engineering Open Access 22 February 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eisenstein, M. Active machine learning helps drug hunters tackle biology. Nat Biotechnol 38, 512–514 (2020). https://doi.org/10.1038/s41587-020-0521-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0521-4
This article is cited by
-
Characterizing emerging companies in computational drug development
Nature Computational Science (2024)
-
Structural insights into inhibition of PRRSV Nsp4 revealed by structure-based virtual screening, molecular dynamics, and MM-PBSA studies
Journal of Biological Engineering (2022)
-
Recent advances in the microbial production of isopentanol (3-Methyl-1-butanol)
World Journal of Microbiology and Biotechnology (2021)